Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Posttransplant lymphoproliferative disorder
- Radiologic Findings
- Fig 1. Chest PA shows multifocal ill defined opacities in both lung fields.
Fig 2. Chest CT scan shows ill-defined GGOs in both lung.
Fig 3-5. In chest CT, multifocal GGO and consolidation have been gradually aggravated during follow-ups despite the empirical treatment.
- Brief Review
- Post-transplantation lymphoproliferative disorders (PTLDs) are defined as lymphomas that occur after transplantation. PTLD is the second most common tumor in adult transplant recipients. Recipients of solid-organ or allogeneic hematopoietic stem-cell transplants have an increased risk of cancers related to immunosuppression and the Epstein–Barr virus (EBV) — in particular, lymphomas. PTLD is most prevalent during the first year following transplantation. In the adult population, recipients of kidney transplants have the lowest incidence of PTLD (0.8 to 2.5%), followed by recipients of pancreatic transplants (0.5 to 5.0%), liver transplants (1.0 to 5.5%), heart transplants (2.0 to 8.0%), and lung transplants (3.0 to 10.0%). For allogeneic hematopoietic stem-cell transplants, the incidence depends mainly on the degree of HLA matching and the highest incidence of PTLD is observed with haploidentical allogeneic hematopoietic stem-cell transplantation.
A pulmonary mass and nodules, either solitary or multiple, are the most common thoracic manifestation of PTLD. Other intrathoracic manifestations include lymph node enlargement, airspace consolidation, and, less commonly, pleural effusion, pericardial effusion, thymic enlargement, and chest wall soft-tissue involvement. Many of the thoracic manifestations are nonspecific for PTLD and can also be seen with transplantation-related complications, particularly infection. Acute rejection may manifest as ground-glass opacities or airspace consolidation, and, although PTLD usually does not develop rapidly, its presence has been reported as early as 1 week following transplantation. FDG PET/CT can increase sensitivity and specificity for the diagnosis; however, biopsy is still necessary for confirmation.
- References
- 1. Dierickx D, Habermann TM. Post-Transplantation Lymphoproliferative Disorders in Adults. N Engl J Med. 2018 Feb 8;378(6):549-562.
2. Borhani AA, Hosseinzadeh K, Almusa O, Furlan A, Nalesnik M. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation. Radiographics. 2009 Jul-Aug;29(4):981-1000.
3. Camacho JC, Moreno CC, Harri PA, Aguirre DA, Torres WE, Mittal PK. Posttransplantation lymphoproliferative disease: proposed imaging classification. Radiographics. 2014 Nov-Dec;34(7):2025-38.
- Keywords